HTGF has returned to back Freiburg's single cell-dispensing spinout Cytena after previously featuring in the company’s $1.3m round in 2015.
Cytena, a Germany-based single-cell printing technology spinout from University of Freiburg, has closed a €3m ($3.4m) series A round featuring public-private partnership High-Tech Gründerfonds (HTGF) and two unnamed angel investors.
Founded in 2014, Cytena markets a range of lab machines that dispense and sort live biological cells to be used in biopharmaceutical drug development as well as cancer and stem cell research applications.
Cytena’s devices quickly isolate each individual cell in well plates with enough capacity for 96…
